Clinical Lab Automation Market to be Worth $4.01 Billion by 2031
Next-generation sequencing (NGS) technology has significantly reduced DNA sequencing costs. Moreover, it has revolutionized the field of genetic disease diagnostics with rapid, high-throughput, and cost-effective approaches. NGS can simultaneously analyze hundreds of genes, the whole exome, and the whole genome, enabling researchers to gain a deeper understanding of unknown species and complex diseases.
Read More: https://www.meticulousresearch.com/product/clinical-lab-automation-market-5762
0 Comments
Recommended Comments
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now